Home > Insider Trading > Filing (0001628280-19-015240)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1576280	Guardant Health Inc.	GH	Services-Medical Laboratories (8071)	454139254

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1753159	Amirali Talasaz	505 Penobscot Drive Redwood City CA 94063	Chairman, President And Coo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-12-17	201	$4.18	71,951	No	4	M	Direct
Common Stock	Disposition	2019-12-17	203	$80.00	71,748	No	4	S	Direct
Common Stock	Disposition	2019-12-17	567	$80.00	3,442,207	No	4	S	Indirect	Shares held by Talasaz and Eskandari 2017 Family Trust
Common Stock	Disposition	2019-12-17	15	$80.00	5,639	No	4	S	Indirect	Shares held by Samar Talasaz 2018 Irrevocable Trust
Common Stock	Disposition	2019-12-17	15	$80.00	5,639	No	4	S	Indirect	Shares held by Sana Talasaz 2018 Irrevocable Trust
Common Stock	Acquisiton	2019-12-19	61,964	$4.18	133,712	No	4	M	Direct
Common Stock	Disposition	2019-12-19	35,845	$80.39	97,867	No	4	S	Direct
Common Stock	Disposition	2019-12-19	26,742	$81.14	71,125	No	4	S	Direct
Common Stock	Disposition	2019-12-19	100,293	$80.39	3,341,914	No	4	S	Indirect	Shares held by Talasaz and Eskandari 2017 Family Trust
Common Stock	Disposition	2019-12-19	74,821	$81.14	3,267,093	No	4	S	Indirect	Shares held by Talasaz and Eskandari 2017 Family Trust
Common Stock	Disposition	2019-12-19	2,690	$80.38	2,949	No	4	S	Indirect	Shares held by Samar Talasaz 2018 Irrevocable Trust
Common Stock	Disposition	2019-12-19	2,019	$81.14	930	No	4	S	Indirect	Shares held by Samar Talasaz 2018 Irrevocable Trust
Common Stock	Disposition	2019-12-19	2,690	$80.38	2,949	No	4	S	Indirect	Shares held by Sana Talasaz 2018 Irrevocable Trust
Common Stock	Disposition	2019-12-19	2,019	$81.14	930	No	4	S	Indirect	Shares held by Sana Talasaz 2018 Irrevocable Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct
No	4	S	Indirect	Shares held by Talasaz and Eskandari 2017 Family Trust
No	4	S	Indirect	Shares held by Samar Talasaz 2018 Irrevocable Trust
No	4	S	Indirect	Shares held by Sana Talasaz 2018 Irrevocable Trust
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Indirect	Shares held by Talasaz and Eskandari 2017 Family Trust
No	4	S	Indirect	Shares held by Talasaz and Eskandari 2017 Family Trust
No	4	S	Indirect	Shares held by Samar Talasaz 2018 Irrevocable Trust
No	4	S	Indirect	Shares held by Samar Talasaz 2018 Irrevocable Trust
No	4	S	Indirect	Shares held by Sana Talasaz 2018 Irrevocable Trust
No	4	S	Indirect	Shares held by Sana Talasaz 2018 Irrevocable Trust

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	STOCK OPTION (RIGHT TO BUY)	Disposition	2019-12-17	201	$0.00	201	$4.18
Common Stock	STOCK OPTION (RIGHT TO BUY)	Disposition	2019-12-19	61,964	$0.00	61,964	$4.18

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
953,044		2022-07-13	No	4	M	Direct
891,080		2022-07-13	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	737,800	Indirect	Shares held by Talasaz Investments, L.P.

Footnotes

These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
Some or all of the shares sold were acquired contemporaneously upon the cashless exercise of stock options at an exercise price of $4.18 per share.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $80.00 to $80.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $81.00 to $81.36, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on April 23, 2017.